Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Ethiopia's salt trails
For centuries merchants have traveled to Ethiopia to collect salt from the surface of the vast desert basin. Slideshow
Sponsored Links
Novartis's smokers' cough treatment gets European nod
An employee smokes a cigarette beside the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011.
Credit: Reuters/Arnd Wiegmann
ZURICH |
ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday the European Commission had approved its Seebri Breezhaler as a once-daily treatment for adult patients with chronic obstructive pulmonary disease, more commonly known as smoker's cough, in the European Union.
Trials showed that the treatment significantly improved lung function over the first four hours after morning dosing when compared to placebo, and that this benefit was sustained for 24 hours over a 52-week period, Novartis said.
The group said the treatment will be available to physicians and patients in some European Union markets by year end.
Deutsche Bank has estimated peak sales for Seebri Breezhaler at some $500 million.
(Reporting by Martin de Sa'Pinto)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
The rest of us should not be required to pay higher insurance premiums to subsidize poor choices by other insured people.
Follow Reuters